All Stories

  1. Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia
  2. Affecting NF-κB cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles
  3. Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study
  4. PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells
  5. How to study dendrimers and dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo
  6. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: Considering their contrary potential as biocompatible entity and drug molecule in cancer
  7. The Influence of Maltotriose-Modified Poly(propylene imine) Dendrimers on the Chronic Lymphocytic Leukemia Cells in Vitro: Dense Shell G4 PPI
  8. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells
  9. Genotoxicity of poly(propylene imine) dendrimers
  10. Modulation of biogenic amines content by poly(propylene imine) dendrimers in rats
  11. The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein—proofs of crossing blood–brain–barrier
  12. Influence of dendrimers on red blood cells
  13. In vivo toxicity of poly(propyleneimine) dendrimers